Impact of the COVID-19 Pandemic on Kidney Diseases Requiring Renal Biopsy: A Single Center Observational Study
Authors:
Open Access
- 8 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12, 649336
Abstract
Background: The coronavirus disease-2019 (COVID-19) pandemic impacted healthcare services for kidney disease patients. Lockdown and social distancing were mandated worldwide, resulting in closure of medical services. The diagnosis of various kidney diseases may have been delayed during the COVID-19 pandemic because non-urgent tests and visits were postponed due to closure of medical services during the lockdown.Methods: We here report the impact of the COVID-19 pandemic on a total number of 209 native kidney diseases requiring renal biopsy for diagnosis in a retrospective observational study from a tertiary hospital in Germany.Results: The lockdown period in March and April 2020 primarily affected patients admitted to the normal medical ward with a compensatory increased rate of renal biopsies in the postlockdown phase. In addition, there was a shift toward more patients admitted with hemoglobinuria during the COVID-19 pandemic. This phenomenon of an increased number of patients with hemoglobinuria during the COVID-19 pandemic was specifically observed in a subgroup with hypertensive nephropathy requiring renal biopsy and associated with increased proteinuria, not attributed to the COVID-19 lockdown period itself.Conclusion: To our knowledge, this is the first report of identifying a subpopulation susceptible to closure of medical services during the COVID-19 pandemic and diagnostic delay of specific kidney diseases. Therefore, the COVID-19 pandemic should be regarded as a risk factor especially in patients with diseases other than COVID-19 primarily admitted to the normal medical ward.Keywords
This publication has 30 references indexed in Scilit:
- Clinical and pathological analysis of the kidney in patients with hypertensive nephropathyExperimental and Therapeutic Medicine, 2013
- Clinical and Pathological Evaluation of Hypertensive Emergency-Related NephropathyInternal Medicine, 2013
- Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertensionJournal Of Hypertension, 2012
- Metabolic Syndrome and Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Metabolic Syndrome and Risk of Developing Chronic Kidney Disease in Japanese AdultsHypertension Research, 2007
- Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trialBMJ, 2006
- Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAALKidney International, 2004
- Predictors of survival and organ damage in Wegener's granulomatosisRheumatology, 2002
- Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injuryAmerican Journal of Kidney Diseases, 2000
- Renal biopsy findings in hypertensive patients with proteinuriaThe Lancet, 1992